Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.
Park KW, Chae IH, Lim DS, Han KR, Yang HM, Lee HY, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Jo SH, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Gwon HC, Jang YS, Kim HS. Park KW, et al. Among authors: hong tj. J Am Coll Cardiol. 2011 Oct 25;58(18):1844-54. doi: 10.1016/j.jacc.2011.07.031. J Am Coll Cardiol. 2011. PMID: 22018294 Free article. Clinical Trial.
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
Gwon HC, Hahn JY, Park KW, Song YB, Chae IH, Lim DS, Han KR, Choi JH, Choi SH, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Jang Y, Kim HS. Gwon HC, et al. Among authors: hong tj. Circulation. 2012 Jan 24;125(3):505-13. doi: 10.1161/CIRCULATIONAHA.111.059022. Epub 2011 Dec 16. Circulation. 2012. PMID: 22179532 Clinical Trial.
Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).
Hur SH, Kim IC, Won KB, Cho YK, Yoon HJ, Nam CW, Kim KB, Kim MS, Park J, Rha SW, Chae SC, Kim YJ, Kim CJ, Cho MC, Jeong MH, Ahn YK, Kim HS, Ahn TH, Seung KB, Jang Y, Yoon JH, Seong IW, Hong TJ, Bae JH, Park SJ; KAMIR (Korea Acute Myocardial Infarction Registry) Investigators. Hur SH, et al. Among authors: hong tj. Clin Cardiol. 2016 May;39(5):276-84. doi: 10.1002/clc.22525. Epub 2016 Mar 30. Clin Cardiol. 2016. PMID: 27028303 Free PMC article.
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe).
Kim KJ, Kim SH, Yoon YW, Rha SW, Hong SJ, Kwak CH, Kim W, Nam CW, Rhee MY, Park TH, Hong TJ, Park S, Ahn Y, Lee N, Jeon HK, Jeon DW, Han KR, Moon KW, Chae IH, Kim HS. Kim KJ, et al. Among authors: hong sj, hong tj. Cardiovasc Ther. 2016 Oct;34(5):371-82. doi: 10.1111/1755-5922.12213. Cardiovasc Ther. 2016. PMID: 27506635 Free PMC article. Clinical Trial.
Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.
Sohn IS, Kim CJ, Ahn T, Youn HJ, Jeon HK, Ihm SH, Cho EJ, Chung WB, Chae SC, Kim WS, Nam CW, Park SM, Choi JY, Kim YK, Hong TJ, Lee HY, Cho JH, Shin ES, Yoon JH, Yang TH, Jeong MH, Lee JH, Park JI. Sohn IS, et al. Among authors: hong tj. Clin Ther. 2017 Aug;39(8):1628-1638. doi: 10.1016/j.clinthera.2017.06.014. Epub 2017 Jul 19. Clin Ther. 2017. PMID: 28734660 Clinical Trial.
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy.
Rhee MY, Kim KJ, Kim SH, Yoon YW, Rha SW, Hong SJ, Kwak CH, Kim W, Nam CW, Park TH, Hong TJ, Park S, Ahn Y, Lee N, Jeon HK, Jeon DW, Han KR, Moon KW, Chae IH, Kim HY, Kim HS. Rhee MY, et al. Among authors: hong sj, hong tj. Clin Ther. 2019 Dec;41(12):2571-2592. doi: 10.1016/j.clinthera.2019.10.010. Epub 2019 Nov 11. Clin Ther. 2019. PMID: 31727361 Clinical Trial.
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mg.
Lee CW, Baek SH, Hong TJ, Choi YJ, Kim YJ, Ahn TH, Ihm SH, Bae JH, Hong SJ, Kim DI, Ahn YK, Hur SH, Park DG, Choi DJ, Lee SU, Kim BS, Ryu KH, Jang YS, Lee SH, Seung KB, Kim HS. Lee CW, et al. Among authors: hong sj, hong tj. Cardiovasc Drugs Ther. 2010 Apr;24(2):181-8. doi: 10.1007/s10557-010-6225-0. Cardiovasc Drugs Ther. 2010. PMID: 20383571 Clinical Trial.
Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR) study.
Park JS, Kim YJ, Shin DG, Jeong MH, Ahn YK, Chung WS, Seung KB, Kim CJ, Cho MC, Jang YS, Park SJ, Seong IW, Chae SC, Hur SH, Choi DH, Hong TJ; Korean Acute Myocardial Infarction Registry (KAMIR) Group. Park JS, et al. Among authors: hong tj. Clin Cardiol. 2010 Aug;33(8):E1-6. doi: 10.1002/clc.20557. Clin Cardiol. 2010. PMID: 20589943 Free PMC article.
Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study.
Park CG, Youn HJ, Chae SC, Yang JY, Kim MH, Hong TJ, Kim CH, Kim JJ, Hong BK, Jeong JW, Park SH, Kwan J, Choi YJ, Cho SY. Park CG, et al. Among authors: hong bk, hong tj. Am J Cardiovasc Drugs. 2012 Feb 1;12(1):35-47. doi: 10.2165/11597170-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 22217192 Clinical Trial.
223 results